Stefan Kohler
Dr. iur. et dipl. sc. nat. ETH Stefan Kohler
VISCHER AG
work Schützengasse 1 Postfach
8021 Zürich
Schweiz
- work +41 58 211 34 19
- stefan.kohler@vischer.com
Stefan Kohler ist spezialisiert auf das Immaterialgüter- und Technologierecht sowie auf die Beratung von Unternehmen in regulierten Märkten wie Gesundheitswesen, Pharma, Medizintechnologie, Biotechnologie, Lebensmittel und Kosmetika. Er vertritt Schweizer und ausländische Firmen regelmässig vor Schweizer Zivil- und Verwaltungsgerichten, Schiedsgerichten und Verwaltungsbehörden. Sein Erststudium der Naturwissenschaften an der ETH Zürich ermöglicht Stefan Kohler die zielgenaue rechtliche Zuordnung von technisch-wissenschaftlichen Sachverhalten.
Stefan Kohler ist nebenamtlicher Richter am Bundespatentgericht, Dozent an der Universität St. Gallen und unterrichtet angehende Patentanwälte am IGE in den Bereichen der Lizenz- und Kooperationsverträge und des Technologietransfers. In seinem Fachgebiet ist Stefan Kohler Autor einer Vielzahl an Publikationen.
Ausbildung
- Universität St. Gallen/ETH Zürich (Dr. iur., 2004)
- Universität St. Gallen, Rechtswissenschaft (lic. iur., 1997)
- ETH Zürich, Naturwissenschaft (dipl. sc. nat. ETH, 1994)
Beruflicher Werdegang
- Berater im International Law Department eines US-amerikanischen Pharmaunternehmens (New Jersey); Gesetzgebungsberatung zum schweizerischen Bio- und Gentechnologierecht
- Lehrbeauftragter an der Universität St. Gallen (seit 2007)
- Lehrtätigkeit in Naturwissenschaften
- Forschungspraktika (Biowissenschaften/Molekularbiologie)
- Rechtswissenschaftlicher Assistent an der Universität St. Gallen
- Anwaltspraktikum und Mitarbeiter in international, wirtschaftsrechtlich orientierten Anwaltskanzleien in Zürich
Mitgliedschaften in berufsbezogenen Vereinen
- Zürcher Anwaltsverband
- Schweizerischer Anwaltsverband
- Licensing Executive Society Schweiz (LES-CH) (Mitglied Vereinsvorstand)
- Swiss Healthcare Startups (Mitglied Vereinsvorstand)
- BioLawEurope (Mitglied Vereinsvorstand)
- International Association for the Protection of Intellectual Property (AIPPI)
- INGRES - Institut für gewerblichen Rechtsschutz
- Mitglied des Forums Genforschung der Schweizer Akademie für Naturwissenschaften
- International Bar Association
Sprachen
- Deutsch
- Englisch
Tätigkeitsgebiete
- Biotechnologierecht
- China Desk
- Datenschutz
- Gesundheitsrecht
- Immaterialgüterrecht
- Life Sciences
- Markenrecht
- Patentrecht
- Pharma
- Prozessführung
- Schiedsgerichtsbarkeit
- Technologierecht
Deals & Cases
Publikationen & Präsentationen
Who's Who Legal Thought Leader (Switzerland 2023) - Life Sciences
Recommended in White-Collar Crime
Leaders League: Switzerland - Best Law Firms 2024
"With his scientific background and in-depth understanding of business and technological topics, he has contributed greatly to both business deals and litigation."
Chambers and Partners (Europe 2024) - Intellectual Property
"We have been working with Stefan Kohler on different projects, some of which have been challenging to deal with besides the day-to-day business. His legal experience, in-depth technical understanding and knowledge as well as a business mindset helped greatly in finding suitable legal solutions. It has always been a pleasure to work with him and his team."
The Legal 500 (EMEA 2024) - Intellectual Property
"Stefan Kohler is a highly committed and competent attorney for litigation, but also for contractual issues. Fantastic to work with and they have a good instinct."
The Legal 500 (EMEA 2024) - Intellectual Property
"‘It is great working with Stefan Kohler, the exceptional team leader of a highly skilled and motivated lawyer team. Stefan’s leadership is exemplary, driving his team to deliver outstanding results. The team’s expertise and dedication are unmatched. I highly recommend Stefan and his team for their exceptional legal services."
The Legal 500 (EMEA 2024) - Intellectual Property
Recommended in Biotechnology Law and Intellectual Property Law
Best Lawyers Switzerland 2025
Stefan Kohler is a highly regarded practitioner who assists with licensing agreements, marketing regulations and other regulatory issues.
Chambers Europe 2023 - Life Sciences
"His knowledge is very important to us, he knows the company in detail, is very skilled and has a great team."
Chambers Europe 2023 - Intellectual Property
‘Stefan Kohler is highly knowledgeable, very dedicated, great communicator, clear, great advice.’
Legal 500 (EMEA 2023) – "Intellectual property"
Stefan Kohler is widely commended for his remarkable experience advising on IP matters affecting major clients in life sciences sector.
Who's Who Legal - Healthcare (2022)
Stefan Kohler is a highly regarded practitioner, assisting with licensing agreements, marketing regulations and other regulatory issues. "He provided very concise, well-elaborated, easy-to-understand legal advice on several legal questions under Swiss law," says one client.
Chambers Europe 2022 – Life Sciences
Stefan Kohler is recognised for his work on counterfeiting disputes and patent litigation. He additionally handles trade mark infringement cases.
Chambers Europe 2022 – Intellectual Property
"Stefan Kohler’s double major in natural sciences and law make him a very valuable patent litigator."
Legal 500 (EMEA 2022) – "Intellectual Property"
"Stefan Kohler provided outstanding legal advice to our clients."
Legal 500 (EMEA 2021) – "Intellectual Property"
"Stefan Kohler is a regulatory specialist who assists domestic and international clients in navigating healthcare and life sciences regulations." He is listed as Global Elite Thought Leader.
Who's Who Legal Thought Leaders (Global 2020) - "Healthcare"
"Stefan Kohler possesses strong experience in IP and technology law, and is active in a plethora of industries including biotech, cosmetics and healthcare."
Who's Who Legal Thought Leaders (Switzerland 2020) - "Patents"
"Stefan Kohler is a standout lawyer distinguished for his expertise in IP law. He brings significant value to clients due to his insights into the biotech, healthcare and pharma markets."
Who's Who Legal Thought Leaders (Switzerland 2020) - "Life Sciences"
Recommended for Life Sciences - Transactional
Who's Who Legal Thought Leaders (Global 2020) - "Life Sciences - Transactional"
Recommended for Patents
Who's Who Legal Thought Leaders (Global 2020) - "Patents"
Key practice areas for VISCHER are capital markets, M&A, healthcare, TMT and transport as well as public law, competition and litigation. Among the names to note are Klaus Neff, Stefan Kohler, Rolf Auf Der Maur, Benedict Christ, David Rosenthal and Stefan Rechsteiner as well as Christian Oetiker, Michael Waldner, and Christian Wyss.
Legal 500 (EMEA 2021) - "Leading firms - German-speaking Switzerland"
The well-established life sciences practice at VISCHER is sought after by a range of players in the industry, including pharmaceutical companies, start-ups and investors. Covering the healthcare, pharmaceutical, biotech and cosmetics sectors, the team handles contentious and non-contentious regulatory and patent matters as well as financing rounds and M&A transactions. Stefan Kohler enjoys a strong reputation among his peers and has experience in IP and technology law. He jointly leads the practice with Basel-based Matthias Staehelin, who is well versed in capital markets, venture capital and agreements in the relevant field. Christian Wyss, also in the Basel office, is noted for his knowledge in R&D, technology transfers and license agreements.
Legal 500 (EMEA 2021) – "Healthcare and Life Sciences"
Stefan Kohler is a highly regarded practitioner, assisting with distribution agreements, marketing regulations and other regulatory issues. One client remarks: "He has an ability to be very practical in his work," in addition to being "very nice to work with."
Chambers Europe 2021 - Life Sciences
Stefan Kohler is recognised for his work on counterfeiting disputes and patent litigation. One client praises him for being "very experienced, committed and responsive."
Chambers Europe 2021 – Intellectual Property
Stefan Kohler is particularly active for life sciences clients, advising on exclusive rights and licensing agreements. He also acts on the IP aspects of transactions, with further strength in counterfeiting matters.
Chambers Europe 2020 - Intellectual Property
Stefan Kohler advises on licensing agreements for drug development and commercialisation, with further activity in product launches. He also offers experience in pricing and reimbursement matters.
Chambers Europe 2020 - Life Sciences
"VISCHER has a strong track record in transactions in the life sciences space, in which it acts for companies, entrepreneurs and investors alike. It is also well versed in advising clients on compliance matters, administrative procedures and other regulatory matters. Stefan Kohler has longstanding experience in the sector and further advises on IP and technology law. He jointly leads the practice alongside Matthias Staehelin in Basel, who is a key contact for M&A, IPOs and financings in this space. Christian Wyss, also in Basel, has considerable knowledge in setting up contracts and assisting start-ups."
Legal 500 (EMEA 2020) - "Healthcare and Life Sciences"
"VISCHER's IP practice handles patent litigation and protection strategies, copyright licensing and agreements for online models and video on demand (VOD) platforms, and trade mark portfolio management. Highlights included team head Stefan Kohler co-ordinating the European market launch of Migros Delica's new coffee capsules compatible with Nespresso machines, and Rolf Auf der Maur successfully defending Swisscom in the first-ever national ISP blocking case. Christian Wyss focuses on due diligence and M&A-related cases."
Legal 500 (EMEA 2020) - "Intellectual Property"
"VISCHER is highly regarded for its healthcare, TMT and transport practices as well as its expertise in capital markets, M&A, public law, competition and litigation matters. Key at the firm include Stefan Kohler, Rolf Auf der Maur, Benedict Christ, Stefan Rechsteiner and Christian Oetiker. Michael Waldner, Klaus Neff and Christian Wyss are other names to note."
Legal 500 (EMEA 2020) - "Leading firms - German-speaking Switzerland"
VISCHER wurde in den Branchen Chemie, Medizinaltechnik und Pharma als eine der fünf am häufigsten empfohlenen Kanzleien ausgezeichnet.
BILANZ-Ranking "Top-Anwaltskanzleien 2020" der Schweiz
"Stefan Kohler of Vischer is a well-known name in the Swiss market who possesses a strong reputation for his deep knowledge of IP regulation and contractual matters."
Who's Who Legal (Switzerland 2019) - "Life Sciences"
"Stefan Kohler is described as "very solution-oriented and a calming influence" by clients, who report that it is "very easy to find an answer with him." He assists clients with patent litigation matters as wel as IP development agreements and licences."
Chambers Europe (2019) - "Intellectual Property"
"Stefan Kohler has a strong track record in regulatory matters and is recognised for his expertise in pricing-related issues and market access questions. He assisted Philip Morris International with the regulatory and liability aspects of the launch of its new product IQOS. A source describes him as "confident and solution-oriented" and lauds his capabilities in the pharmaceutical industry."
Chambers Europe (2019) - "Life Sciences" - Band 1
"VISCHER is renowned for its expertise in corporate, commercial, transactional, regulatory and patent-related healthcare and biotech matters. Matthias Staehelin assisted Medartis with its initial public offering on the SIX Swiss Exchange, while Stefan Kohler acted for Novo Nordisk Pharma in its appeal against a pricing decision made by the Swiss Federal Office of Public Health concerning the client's type-two diabetes product. Christian Wyss advised Lundbeck on its €905m acquisition of Prexton Therapeutics."
Legal 500 (EMEA 2019) - "Healthcare and Life Sciences" - Tier 1
"The intellectual property department at VISCHER covers protective, strategic, transactional and contentious matters in relation to patents, copyright, designs and trade marks. Christian Wyss assisted Balderton Capital with the IP due diligence in preparation for its investment into Sophia Genetics' $30m financing round, while team lead Stefan Kohler advises Philipp Morris on the agreements required for the technological development of reduced-risk tobacco products. Rolf Der Maur, who combines intellectual property law with IT expertise, is another name to note."
Legal 500 (EMEA 2019) - "Intellectual Property"
"VISCHER has core strength in the healthcare, TMT and transport sectors and notable public law expertise, while also fielding strong capital markets, M&A, competition and litigation departments. Key partners include Stefan Kohler, Rolf Auf der Maur, Stefan Rechsteiner, Benedict Christ and Christian Oetiker. Michael Waldner and Christian Wyss are other names to note."
Legal 500 (EMEA 2019) - "Leading Firms: German-Speaking Switzerland"
"Stefan Kohler at VISCHER is a key player in the market who sources describe as 'an excellent patent litigator', adding that he is also 'very strong at handling regulatory matters'."
Who's Who Legal (Switzerland 2018) - "Life Sciences"
"Vischer provides transactional, financing, capital markets, product launch and regulatory advice to health and life sciences industry clients and further represents them in contentious matters. The practice assisted JSR Corporation with its acquisition of Selexis and advised Axovant Sciences on its debt financing agreement with Hercules Capital. Stefan Kohler jointly heads the practice with Matthias Staehelin; Christian Wyss is another name to note."
Legal 500 (EMEA 2018) - "Healthcare and life sciences" - Tier 1
"Stefan Kohler is 'very open and approachable,' according to one source, who also notes that he is a 'good adviser.' He successfully represented Novo Nordisk Pharma in an appeal regarding pricing orders and has further experience relating to negotiations and the implementation of new regulations, as well as compliance and liability risk issues."
Chambers Europe (2018) - "Life Sciences"
" Stefan Kohler advises clients from the pharmaceutical, retail, technology and automotive sectors on matters such as trade mark enforcement and cancellation procedures. He has further experience in patent applications, as well as advising on the new 'Swissness' legislation and R&D and licence agreements."
Chambers Europe (2018) - "Intellectual Property"
"Vischer’s team has been representing Westwind in a patent dispute regarding heat exchange technology and assisted Netflix with copyright matters. The ‘very skilled and knowledgeable’ Stefan Kohler is an expert for patent and trade mark matters, while Rolf Auf der Maur is recommended for copyright work."
Legal 500 (EMEA 2017) - "Intellectual Property"
"Stefan Kohler from Vischer is a 'frontrunner' in the market, singled out for his ability to 'make complex matters seem simple'."
Who's Who Legal (Switzerland 2016) - "Life Sciences"
"Vischer is represented by 'top lawyer' Stefan Kohler. He focuses on the legal issues concerning the development and marketing of innovative technologies. He also lectures aspiring patent attorneys and authors a range of publications in the area."
Who's Who Legal (Switzerland 2015) - "Patents"
"The ‘very hardworking team’ at Vischer provides ‘commercial solutions to legal problems’. It successfully represented IVF Zentren Prof. Zech before the Cantonal Administrative Court of St Gallen, which overturned a health department ban on cryopreservation of oocytes to preserve female fertility. It also assisted AstraZeneca with the acquisition of Spirogen. Matthias Staehelin leads the practice alongside Stefan Kohler, who has ‘broad knowledge’ and ‘a friendly negotiation style’."
Legal 500 (EMEA 2015) - "Healthcare and life sciences" - 1st tier
"Vischer’s Stefan Kohler is recommended for pharmaceuticals patent and trade mark matters, and Rolf Auf der Maur is an expert in media sector copyrights and trade marks. Clients include Mattern Pharmaceutical, V-Zug, 3 Plus and Swisscom."
Legal 500 (EMEA 2015) - "Intellectual property"
"Practice head Stefan Kohler is recommended for his excellent knowledge of the life sciences sector and his patent experience. Sources comment: 'He has excellent industry knowledge and is very well connected.'"
Chambers Europe (2015) - "Intellectual Property"
"Department co-head Stefan Kohler is singled out for his 'excellent industry knowledge' as well as his strong regulatory and corporate expertise. Sources enthuse: 'He is very commercial and very focused on getting the deal done; he is always at the front of the transaction.'"
Chambers Europe (2015) - "Life Sciences" - 1st tier
"Across town at Vischer, Stefan Kohler leverages his scientific background to forge crucial pharmaceutical agreements. His 'specific biotech know-how' is singled out for special mention."
iam - 1000 - World's Leading Patent Professionals 2015
"Vischer has an ‘excellent’ regulatory practice, including compliance and administrative procedures, remarkable IP capabilities and a niche in acting for emerging biotech companies, where it advised GlycoVaxyn and Redvax on their sales to GlaxoSmithKline and Pfizer, respectively. Other clients include AstraZeneca, Novartis, Mattern Pharmaceuticals and IVF Zentren Prof. Zech. Stefan Kohler has ‘very broad knowledge’, including regulatory and IP matters, and is recommended along with Matthias Staehelin and newly promoted partner Christian Wyss."
Legal 500 (EMEA 2016) - "Healthcare and Life Sciences" - 1st tier
"Vischer’s Stefan Kohler is recommended for pharmaceuticals patent and trade mark matters, and Rolf Auf der Maur is recommended for copyrights and trade mark matters, most notably in the media sector. Clients include Netflix, 3 Plus and AstraZeneca."
Legal 500 (EMEA 2016) - "Intellectual Property"
"Vischer has been representing Swiss International Air Lines in an administrative dispute regarding a licence for flights between Geneva and Lugano, which was appealed by competitor Darwin Airlines. The firm also successfully represented the utility company EKZ in a dispute with competitor AET regarding the right to supply electricity to the construction site of the Alp Transit Gotthard tunnel. Other clients include Swisslos and the University Hospital of Zurich. ‘Very knowledgeable’ practice head Stefan Rechsteiner is recommended along with Andreas Albrecht and Stefan Kohler."
Legal 500 (EMEA 2016) - "Public Law" - 1st tier
"Sources applaud Stefan Kohler's 'capacity in the life sciences and pharmaceutical field,' drawing particular recognition for his activity in patent matters."
Chambers Europe (2016) - "Intellectual Property"
"Market commentators identify co-head of department Stefan Kohler as a leading expert in the regulatory field. Clients state that 'he understands and he tries to really capture your problem.'"
Chambers Europe (2016) - "Life Sciences" - Band 1
"At Vischer, Stefan Kohler is 'one of the foremost' lawyers in the Swiss market and regularly advises companies in relation to life sciences regulatory matters as well as legal issues arising out of the development and marketing of innovative technologies."
Who's Who Legal (Switzerland 2015) - "Life Sciences"
Recommended for Biotechnology Law, Intellectual Property Law.
Best Lawyers Switzerland 2014 - 2023
"Stefan Kohler of Vischer is acclaimed for 'his extensive biotech know-how'."
iam – World's Leading Patent Practitioners 2014
"Stefan Kohler focuses on legal matters surrounding the development and marketing of innovative technologies, and is highlighted by market sources for his life sciences know-how. 'He's a good strategic thinker,' praise interviewees, who also say they appreciate Kohler's commercial awareness."
Chambers Europe (2014) - "Intellectual Property"
"Vischer's Stefan Kohler is the 'first port of call' for companies concerned with the development and marketing of innovative technologies. He has experience in patent litigation and licensing."
Who's Who Legal (Switzerland 2014) - "Patents"
"Stefan Kohler at Vischer has extensive experience in patent, licensing and regulatory matters and is able to combine 'useful scientific knowledge with important legal concepts' which allows him to provide 'first class advice' to clients."
Who's Who Legal (Switzerland 2014) - "Life Sciences"
"Stefan Kohler leads Vischer’s team, which is known for its copyright expertise, particularly relating to new media and entertainment. It also handles IT and trade mark matters. Rolf Auf der Maur is recommended for his expertise in copyright law relating to new technology."
Legal 500 (EMEA 2014) - "Intellectual property"